SKP2 and posterior cortical atrophy: Our findings revealed increased SKP2 expression in recurrent PCa and NEPC (Fig. 1F,G; Fig. S3c) as well as increased SKP2:FOXA1 protein ratios at stage IV PCa in human prostate TMA (Fig. 1C–E; Fig. S2).